• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

BloodCenter of Wisconsin Launches Pilot Program to Digitally Track Blood Via RFID

by HITC Staff 02/08/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

BloodCenter of Wisconsin Launches Pilot Program to Track Blood Digitally Via RFID

BloodCenter of Wisconsin, part of Versiti, and Fresenius Kabi, have launched a pilot program at Children’s Hospital of Wisconsin using radio frequency identification technology (RFID) to digitally track blood usage and inventory. As part of the pilot, the program will use specialized RFID tags applied to blood bags prior to shipment to hospitals that can automatically as the blood moves through the hospital, and to the point at which it is used to treat patients.  This process allows for real-time information designed to help health care professionals optimize the availability of their blood supply.

The RFID technology electronically tracks the blood from the time it leaves BloodCenter of Wisconsin, to the hospital’s transfusion service area, and on to use of the products.  Children’s Hospital and BloodCenter can jointly look at the movement of products to better inform immediate need and inventory status. The CompoTrace pilot program at BloodCenter of Wisconsin and Children’s Hospital began in October 2016 and will conclude in February 2017. BloodCenter of Wisconsin spearheaded the use of RFID technology in non-pediatric transfusion medicine environments in 2006 under a National Institutes of Health grant.

“Getting the right blood products to the right patient more efficiently helps to reduce costs, which is a critical priority in health care today,” said Dean Gregory, president, Medical Devices, for Fresenius Kabi in North America in a statement.  “We call this technology ‘CompoTrace’ and it’s designed specifically to help improve the vital supply chain of care between blood centers, hospitals and patients.”

Fresenius Kabi is planning similar projects at other hospitals in 2017. 

Featured image credit: Flickr

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: RFID

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |